ArticleBMC microbiology2026
Bioactive metabolites from marine fungal sources: evaluation of antimicrobial and cytotoxic activities.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marine associated fungi were isolated from marine sponges collected at two ecologically distinct localities in Hurghada. Macroscopic characteristics were employed to identify and classify distinct fungal strains using ethanol-hypochlorite surface sterilization. The fungal isolates, identified as marine fungi, were cultivated on Egyptian white rice media to yield bioactive crude extracts following ethyl acetate extraction. The most potent isolate was strain DI7S9. This strain, morphologically and genetically identified as Penicillium rubens (GenBank: OP709283.1), was extensively fermented to yield biomass for subsequent experiments. The primary component of the extract was trans-9-octadecenoic acid, pentyl ester, as determined by GC-MS analysis. According to SwissADME, this compound exhibits moderate drug-likeness, limited gastrointestinal absorption, and low permeability across the blood-brain barrier. The crude extracts exhibited selective cytotoxicity, effectively inhibiting malignant HCT-116 and A-498 cells at low IC₅₀ values (30.44 and 37.99 µg/mL), while inflicting minimal damage on normal HEK-293 cells (IC₅₀ = 77.89 µg/mL). Notable suppression of E. coli, S. aureus, A. niger, and C. albicans was observed. The metabolites of P. rubens DI7S9 exhibit significant pharmacological potential, warranting further investigation into their mechanisms of action and potential therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.